Inpharma Weekly

, Volume 1409, Issue 1, pp 8–8 | Cite as

Darifenacin may prolong warning time in patients with overactive bladder syndrome

Media release
  • 4 Downloads

Keywords

Placebo Multicentre Study Placebo Recipient Medium Release Overactive Bladder 

Copyright information

© Adis International Ltd 2003

Personalised recommendations